Vulnerability in Smiths-Medical Cadd-Solis Medication Safety Software

CVE-2016-8358

An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints.

Published · last modified .

CVSS v3 metric

CVSS v3 base score 8.5 (High). Vector: CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.005 (40.5th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 41st percentile — 40.5% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2016-8358: held from 0.005 to 0.005.

EPSS over last 30 days · oldest: 0.005 · newest: 0.005 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2016-8358?
CVE-2016-8358 is a high-severity vulnerability in Smiths-Medical Cadd-Solis Medication Safety Software, classified under Origin Validation Error. CVSS score: 8.5/10. Published 2017-02-13.
How severe is CVE-2016-8358?
High severity. CVSS v3 base score is 8.5 out of 10.